This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

WEB REGISTRATION CLOSES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Dr. Songjun Xiao, PhD
process development senior scientist at LGC Axolabs
Speaker

Profile

Dr. Songjun Xiao's research interests lie in the highly interdisciplinary field of bioorganic chemistry, with a particular focus on nucleic acid chemistry, bioconjugation, sequencing, and genomics. He earned his Ph.D. from the University of Maryland in 2020 under the mentorship of Prof. Jeff Davis, where his research concentrated on nucleoside chemistry and supramolecular chemistry. Following this, he conducted postdoctoral research at the University of Utah in Prof. Cindy Burrows' lab, specializing in DNA/RNA damage and modification sequencing. Since joining LGC Axolabs in 2022 as a process development scientist, Songjun has been dedicated to the production and optimization of sgRNA and other nucleic acid therapeutics. Beyond his professional pursuits, he finds enjoyment in traveling and playing and watching tennis in his leisure time.

Agenda Sessions

  • Optimizing Production of Chemically Modified sgRNA with High Quality

    12:05pm